The US Food and Drug Administration has approved Hibsago, the medicine bepirovirsen, for use alongside existing antiviral therapy in a defined group of adults with chronic hepatitis B. The October 20 decision offers some patients the possibility of maintaining viral control after treatment ends, but is not a cure for everyone with the infection. Eligibility The post US approves Hibsago for selected adults with chronic hepatitis B appeared first on PakTribune.
GrowthPakistan brings you the latest news to keep an eye on Pakistan’s startup ecosystem. Business keeps you growing when you stay aware of your competitors' moves. GrowthPakistan offers Business, Tech, Global Tech, Global, Auto, and Startup News straight from industries all around the globe. This platform will help you identify upcoming opportunities not only in Pakistan but worldwide.
Email : growthpakistan@gmail.com
Whatsapp : +92320-9497079
© growthpakistan